Charatcharoenwitthaya Phunchai, Soonthornworasiri Ngamphol, Karaketklang Khemajira, Poovorawan Kittiyod, Pan-Ngum Wirichada, Chotiyaputta Watcharasak, Tanwandee Tawesak, Phaosawasdi Kamthorn
Department of Medicine, Faulty of Medicine Siriraj Hospital Department of Tropical Hygiene Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University Vichaiyut Hospital and Medical Center, Bangkok, Thailand.
Medicine (Baltimore). 2017 Aug;96(32):e7782. doi: 10.1097/MD.0000000000007782.
Hospitalizations for advanced liver disease are costly and associated with significant mortality. This population-based study aimed to evaluate factors associated with in-hospital mortality and resource use for the management of hospitalized patients with cirrhosis.Mortality records and resource utilization for 52,027 patients hospitalized with cirrhosis and/or complications of portal hypertension (ascites, hepatic encephalopathy, variceal bleeding, spontaneous bacterial peritonitis, or hepatorenal syndrome) were extracted from a nationally representative sample of Thai inpatients covered by Universal Coverage Scheme during 2009 to 2013.The rate of dying in the hospital increased steadily by 12% from 9.6% in 2009 to 10.8% in 2013 (P < .001). Complications of portal hypertension were independently associated with increased in-hospital mortality except for ascites. The highest independent risk for hospital death was seen with hepatorenal syndrome (odds ratio [OR], 5.04; 95% confidence interval [CI], 4.38-5.79). Mortality rate remained high in patients with infection, particularly septicemia (OR, 4.26; 95% CI, 4.0-4.54) and pneumonia (OR, 2.44; 95% CI, 2.18-2.73). Receiving upper endoscopy (OR, 0.29; 95% CI, 0.27-0.32) and paracentesis (OR, 0.93; 95% CI, 0.87-1.00) were associated with improved patient survival. The inflation-adjusted national annual costs (P = .06) and total hospital days (P = .07) for cirrhosis showed a trend toward increasing during the 5-year period. Renal dysfunction, infection, and sequelae of portal hypertension except for ascites were independently associated with increased resource utilization.Renal dysfunction, infection, and portal hypertension-related complications are the main factors affecting in-hospital mortality and resource utilization for hospitalized patients with cirrhosis. The early intervention for modifiable factors is an important step toward improving hospital outcomes.
晚期肝病的住院治疗费用高昂,且死亡率很高。这项基于人群的研究旨在评估与肝硬化住院患者的院内死亡率及管理资源利用相关的因素。从2009年至2013年全民医保覆盖计划覆盖的泰国住院患者全国代表性样本中,提取了52027例因肝硬化和/或门静脉高压并发症(腹水、肝性脑病、静脉曲张出血、自发性细菌性腹膜炎或肝肾综合征)住院患者的死亡率记录和资源利用情况。院内死亡率从2009年的9.6%稳步上升12%至2013年的10.8%(P<0.001)。除腹水外,门静脉高压并发症与院内死亡率增加独立相关。医院死亡的最高独立风险见于肝肾综合征(比值比[OR],5.04;95%置信区间[CI],4.38 - 5.79)。感染患者的死亡率仍然很高,尤其是败血症(OR,4.26;95%CI,4.0 - 4.54)和肺炎(OR,2.44;95%CI,2.18 - 2.73)。接受上消化道内镜检查(OR,0.29;95%CI,0.27 - 0.32)和腹腔穿刺术(OR,0.93;95%CI,0.87 - 1.00)与患者生存率提高相关。经通胀调整后的全国肝硬化年度费用(P = 0.06)和总住院天数(P = 0.07)在5年期间呈上升趋势。除腹水外,肾功能不全、感染和门静脉高压后遗症与资源利用增加独立相关。肾功能不全、感染和门静脉高压相关并发症是影响肝硬化住院患者院内死亡率和资源利用的主要因素。对可改变因素进行早期干预是改善医院治疗效果的重要一步。